PFARMA PFARMA
  • Home
  • Notícias
    • Mercado
    • Carreira
    • Legislação
    • Estudos e Pesquisas
    • Eventos
    • Saúde
    • Cannabis Medicinal
  • Blog
  • Emprego
  • Estágio
  • Alertas
  • Seleções
    • Trainee
    • Mestrado | Doutorado
    • Residência Farmácia
    • Docente Farmácia
    • Concursos
Detalhes
Categoria: Pharmaceuticals News
By Fábio Reis
Fábio Reis
15.Mar

Texas Judge Considers Revoking FDA Approval of Abortion Pill in US

misoprostol cytotec

Texas Federal Judge Considers Revoking FDA Approval of Abortion Pill in Potentially Nationwide Ban

 

 

A Texas judge is currently hearing arguments regarding the sale of the commonly used abortion pill, mifepristone, in the US. The lawsuit, filed by an anti-abortion group in Texas, argues that the drug's safety was never properly studied and the drug was approved by the FDA before adequate testing was carried out. The case will be decided by Judge Matthew Kacsmaryk, an appointee of former President Donald Trump, and his ruling could curtail access to the drug nationwide.

Mifepristone is taken at home and is used in over half of US pregnancy terminations. If Judge Kacsmaryk rules the FDA erred in its approval, sales of the drug - one of only two pills used to induce an abortion - could be halted. However, women would still be able to use the other approved abortion drug, misoprostol.

The FDA has reported a total of 26 deaths associated with mifepristone since it was approved in 2000 - a rate of about 0.65 deaths per 100,000 by-pill abortions. The drug has been approved for use for over 20 years, and President Joe Biden's administration argues that its approval was well-supported by science.

The high-stakes hearing is the first time Judge Kacsmaryk has engaged directly with lawyers for the Justice Department, representing the FDA; the company that manufactures and distributes the drug; and the anti-abortion group challenging the medication. Protestors are expected outside the federal court in Amarillo.

A Texas federal judge appointed by Donald Trump is considering revoking the FDA's approval of medication abortion in the US, according to a report by The Guardian. The judge, Matthew Kacsmaryk, appeared open to arguments made by a far-right group during a hearing, which could potentially lead to the nationwide banning of the abortion pill. Kacsmaryk stated that he would rule on the case "as soon as possible." In other news, a feud between Trump and Ron DeSantis is ongoing, with Trump's campaign planning to attack the Florida governor's record. A group linked to the ex-president has also filed a formal complaint over DeSantis's "shadow presidential campaign."

Medication-induced abortion has become increasingly contentious since the US Supreme Court's historic overruling last year of the constitutional right to abortion. Twelve Democratic-led states have filed a separate lawsuit against the FDA seeking to make access to mifepristone easier.

 

 

 

 

Artigo anterior: Is it true that the COVID-19 vaccine causes stroke and releases fibrins? Is it true that the COVID-19 vaccine causes stroke and releases fibrins?

Novos conteúdos

  • O futuro dos medicamentos com as cápsula de Pullulan
    O futuro dos medicamentos com as cápsula de Pullulan
    Mercado Farmacêutico 19.Ago
  • Ativa Logística investe R$ 14,8 milhões e amplia operações em São Paulo, Paraná e Espírito Santo
    Ativa Logística investe R$ 14,8 milhões e amplia operações em São Paulo, Paraná e Espírito Santo
    Mercado Farmacêutico 19.Ago
  • Déficit de 4,1 milhões de enfermeiros até 2030, alerta OMS
    Déficit de 4,1 milhões de enfermeiros até 2030, alerta OMS
    Saúde 19.Ago
  • Transformando Dados em Saúde Pública: A Janela de Oportunidade do Decreto n.º 12.560/2025
    Transformando Dados em Saúde Pública: A Janela de Oportunidade do Decreto n.º 12.560/2025
    Saúde 19.Ago
  • Vendas de medicamentos genéricos crescem mais de 7% na região Sul em 2025
    Vendas de medicamentos genéricos crescem mais de 7% na região Sul em 2025
    Mercado Farmacêutico 19.Ago
  • Vendas de medicamentos genéricos crescem mais de 10% na região Norte em 2025
    Vendas de medicamentos genéricos crescem mais de 10% na região Norte em 2025
    Mercado Farmacêutico 19.Ago
  • Esfera Brasil e EMS reúnem Geraldo Alckmin, Hugo Motta, Alexandre Padilha e Gilmar Mendes em fórum sobre saúde
    Esfera Brasil e EMS reúnem Geraldo Alckmin, Hugo Motta, Alexandre Padilha e Gilmar Mendes em fórum sobre saúde
    Blog 05.Ago

Institucional

  • Quem somos
  • Contato
  • Politica de Privacidade
  • Política de Cookie
  • Mapa do Site

Especial

  • Coronavírus
  • Dengue
  • Farmacêutico

PFARMA é um portal de utilidade pública sem fins lucrativos